Medicine Supply Notification: Sodium cromoglicate (Intal® ) CFC-free 5mg inhaler
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sodium cromoglicate (Intal®) CFC-free 5mg inhaler.
• Sanofi are discontinuing Intal® CFC-free 5mg inhalers with stock expected to be exhausted by the
end of January 2022.
•No alternate chromone inhalers are available.
A copy of this medicine supply notification has been sent to all pharmacy NHS email addresses.
The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.